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In hepatosplenic  schistosomiasis mansoni,  the  pathological  effects can  be largely 
attributed  to  the T  lymphocyte-mediated granulomatous  host  response  (1,  2).  The 
chronic  granulomatous  inflammations  terminate  in  reparative  fibrosis,  which  can 
lead to portal hypertension, esophageal varices, bleeding, and death (3). Andrade and 
Warren (4, 5)  first showed, that mice with chronic schistosomiasis at the late stage of 
the  infection  displayed  a  spontaneous  diminution  in  granuloma size,  with  a  corre- 
sponding improvement in the clinico-pathological parameters of the disease. Periodic 
injection of eggs has shown that whereas at 8 wk of the infection mice mounted large 
pulmonary granulomatous reactions, beyond  16 wk granuloma formation decreased 
significantly,  thus  indicating  a  desensitization  process  (6).  Further  analysis showed 
that  this  process entailed  complex changes  in  the  humoral  and  cell-mediated  egg- 
specific immune responses as well as the lymphocyte dynamics of the infected mice. 
Thus, passive hemagglutination  and passive cutaneous anaphylaxis tests showed an 
increase  in  the  level  of circulating  anti-soluble  egg  antigen  (SEA) 1 antibodies.  In 
contrast, delayed footpad reaction of infected mice was abrogated, and no migration 
inhibition factor (MIF)- or eosinophil stimulation promoter (ESP)-active lymphokines 
were  produced  by  cultured  lymphoid  cells  (7,  8).  A  change  in  the  ratios  of T:B 
lymphocytes was also demonstrable in the blood, lymphoid organs, and granulomas 
of the chronically infected mice (9). So far both humoral- and cell-mediated regulatory 
mechanism  have  been  considered  to  act  in  the  modulation  of the  granulomatous 
response. Antibody-mediated afferent immunologic blockade ofgranuloma formation 
has been described by Pelley and Warren (10), and the presence and active synthesis 
of  immunoglobulins  and  anti-SEA  antibodies  within  liver  granulomas  has  been 
reported (11,  12). On the cellular side, adoptive transfer of lymphoid cells from mice 
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undergoing modulation successfully suppressed the granulomatous response in recip- 
ient  mice  (13).  Characterization  of the suppressor  lymphocytes suggested  that  they 
are  cyclophosphamide-sensitive  T  cells  (14).  Further  adoptive  transfer  studies  have 
shown that Ia antigen-bearing T  lymphocytes are required  for the suppress!on of the 
egg-specific  inflammatory  response.  Because  a  significant  increase  occurred  in  the 
numbers  of Thy-l.2 +, Ia  + lymphocytes of the  suppressed  granuloma  after  adoptive 
transfer  of T  suppressor  cells,  the  conclusion  was  reached  that  these  cells  may  be 
involved in the regulation of the granulomatous response (15). Isolated, cultured liver 
granulomas of infected mice were shown to produce MIF and ESP-active lymphokines 
(16,  17). Thus, such mediators are considered to be responsible for the initiation  and 
maintenance of the granulomatous response. To further explore the role of suppressor 
T  lymphocytes in the regulation of the granulomatous response, we characterized the 
splenic lymphocytes of infected mice active in lymphokine production and suppres- 
sion.  The  MIF-producing T  lymphocytes found  at  8  wk  in  the  spleens  of infected 
mice belonged  to  the  Lyt-1  +  subclass  of cells,  and  did  not  express  Ia antigens.  In 
contrast, the suppressor cells detectable at 20 wk of the infection were Lyt-2  + and also 
expressed I-J and I-C subregion-encoded determinants.  Because the latter cells mixed 
with  Ly-1  +  cells  in  vitro  abrogated  MIF  production,  it  is  postulated  that  the 
modulation of granulomatous hypersensitivity may be the result of T-T cell interac- 
tions that regulates lymphokine production. 
Materials  and Methods 
Animals and Infection.  Female, CBA/J(H-2  k) mice obtained from The Jackson Laboratory, 
Bar  Harbor,  Maine  were  used  in  all  experiments.  Mice  were  maintained  under  standard 
laboratory care.  7- to 8-wk-old mice were  injected  subcutaneously with  25  cercariae of the 
Puerto Rican strain of Schistosoma mansonL 
Preparation of SEA.  SEA were prepared from eggs isolated from the livers  of infected mice 
(18) as described previously (2). 
Preparation of Cells.  Splenic T cells were isolated by the method of Mage et al.  (19). Briefly, 
specific  rabbit  anti-mouse IgG antibodies  (RAMab)  directed against  light  and heavy chains 
were prepared from 25 ml of rabbit anti-mouse IgG serum (Miles Laboratories Inc., Elkhart, 
Ind.)  with standard  immunoaffinity techniques.  5 ml of a  25 #g/ml solution of RAMab in 
phosphate-buffered saline (PBS)  (pH 7.4) was distributed  onto  100-mm tissue culture dishes 
(BioQuest, Becton, Dickinson & Co., Oxnard, Calif.) and incubated at 4°C overnight to allow 
for passive binding of antibodies to the plastic. After rinsing the dishes five times with 5 ml of 
PBS, 5 ×  107 spleen cells suspended in 5 ml of RPMI-1640 medium that contained 20 mM 
Hepes buffer (Grand Island Biological Co., Grand Island, N. Y.) were added to each dish. The 
dishes were then incubated for a total of 1 h at room temperature with a single agitation at 30 
min.  After  B  cell  adherence  was  complete,  the  nonadherent  T  cell-enriched  fraction  was 
collected by gentle rinsing of the dishes with RPMI-Hepes. This preparation contained >80% 
Thy~ 1-bearing cells with a total recovery of >90%. 
Antisera and Complement Treatments.  Anti-Thy-l.2 serum was obtained from Bionetics Labo- 
ratory  Products,  Litton  Bionetics  Inc.,  Kensington,  Md.  This  preparation  killed  >95%  of 
normal CBA thymocytes and <3% of normal bone marrow cells. Anti-Lyt-1.1 and anti-Lyt-2.1 
sera were the generous gifts of Dr. F.-W. Shen (Sloan-Kettering Cancer Institute, New York). 
Anti-I(ABJ)  k [(A.BY ×  B10.HTT) anti-A.TL], anti-I(E  u) [(B10.D2 ×  A.BY) anti-B10.A(3R)], 
anti-I(A  k) [ATFR.5 ×  B10.S(9R) anti-A.TL], anti-I(J  k) [B10.HTT anti-B10.S(9R)], anti-I(C  k) 
[(A ×  B10) anti-B10.AM], and anti-I(EC  k)  [B10.S(7R) anti-Bl0.HTT]  sera were prepared at 
the Mayo Medical School, Rochester, Minn. 
Rabbit  serum  absorbed  with  mouse  tissues  (Cedarlane  Laboratories,  London,  Ontario) 
served as a  source of complement. The antisera  and complement were used  for cell  lysis as 
follows:  Spleen cells  (1  ×  107/ml)  were incubated for 30 min at  4°C in antiserum diluted  in 1400  REGULATION OF  MIGRATION INHIBITION FACTOR  PRODUCTION 
RPMI (anti-Lyt- 1.1,  1  : 100; anti-Lyt-2.1,  1:50; all others,  1  : 10). Control sera consisted of mock 
anti-Thy-1.2 (Bionetics Laboratory Products, Litton Bionetics Inc.) serum or normal  (BALB/c 
×  C57BL/6)F1 serum. After incubation, cells were washed by centrifugation at 4°C, suspended 
to their original volume in a  1:10 dilution of complement, and  then  incubated  for 30 min at 
37°C. After incubation,  cells were washed  from two to three times. Viability was determined 
by trypan  blue staining,  and  cell concentrations  were adjusted  according  to  the  number  of 
viable cells. 
Preparation of Supernates That Contained MIF.  Spleen cells were suspended  to a  concentration 
of 1 ×  107 cell/ml in RPMI-1640 medium that contained  10% heat-inactivated normal human 
serum (NHS) (Grand Island Biological Co.) (adsorbed with 1:5 vol of a mixture of mouse spleen 
and  peripheral  blood  cells for  30  min  at  room  temperature),  2  mM  glutamine,  100  U/ml 
penicillin, 100 pg/ml streptomycin (Grand Island Biological Co.), and  1 pg/ml of SEA (RPMI- 
NHS). 2 ml of suspension were distributed  into  16- ×  125-mm tissue culture tubes  (BioQuest, 
Becton, Dickinson & Co.) and incubated at 37°C for 24 h  in a humidified 5% CO2 atmosphere. 
After incubation,  the  tubes  were centrifuged  at  500 g  for  10  min,  and  the supernates  were 
collected from above the cell pellet and then stored at -70°C. Cultures were usually prepared 
in  triplicate  or  quadruplicate.  The  MIF  activity  of the  supernates  was  detected  with  the 
standard  capillary migration inhibition assay described below. 
Assays for MIF Activity.  Normal  peritoneal  exudate  cells  (NPEC)  were  induced  in  virgin 
CBA mice by the injection of 2.0 ml i.p. of light mineral oil (Marcol 52, Exxon Chemical Co., 
Houston,  Tex.).  4-5 d  later,  the NPEC were harvested  aseptically with siliconized glassware. 
The cells were washed  four times in RPMI, counted, and then adjusted  to 4  ×  10 v cell/ml in 
RPMI-NHS without SEA. Assay ofsupernates was performed as described by David (20).  The 
NPEC were placed into glass clot tubes  (70- ×  l-ram)  (Arthur H. Thomas Co., Philadelphia, 
Pa.)  with a  seal at one end. The tubes were then centrifuged for 3 rain at  200 g  to pellet the 
cells. With an aseptic technique,  the tubes were cut at  the cell-medium interface and  placed 
into Sykes-Moore chambers (Bellco Glass, Inc., Vineland, N. J.). The chambers were filled with 
control or test supernates diluted  1:1 with fresh medium and then incubated  18-24 h at 37°C. 
Assays were performed in duplicate with three capillary tubes per chamber.  After incubation, 
the cell migration patterns were projected and traced with an overhead projecting microscope 
(Bausch & Lomb Inc., Analytical Systems Div., Rochester, N. Y.). The area of migration was 
measured  from  the tracings  by planimetry  (Los Angeles Scientific Instrument  Co.,  Inc.,  Los 
Angeles, Calif.). 
Direct  assay  of MIF-producing  cells was  performed  as  described  by  David  et  al.  (21).  1 
million NPEC, supplemented  with 25-100 ×  103 spleen cells, were placed into clot tubes and 
subjected to the migration inhibition assay in the presence of RPMI-NHS as described above. 
Controls were exposed to RPMI-NHS without antigen or consisted of unsupplemented  NPEC 
exposed to antigen. 
Assay  for Suppression of MIFActivity.  In this technique, peritoneal exudate cells were obtained 
from sensitized mice (SPEC) as follows: normal 7- to 8-wk-old CBA mice were each injected in 
the  nape  of the  neck  with  0.1  ml  s.c.  of complete  Freund's  adjuvant  (Difco  Laboratories, 
Detroit, Mich.)  that contained 30 pg of SEA, 5 d  later the mice were given an injection of 2.0 
ml  i.p.  of light  mineral  oil.  4  d  after  oil  injection  (day  9  of sensitization),  the  SPEC  were 
harvested and washed as described above. This protocol of sensitization was predetermined as 
optimal for obtaining SPEC that  gave consistent migration inhibition in the presence of 0.5-5 
pg/ml SEA or 0.5-5/xg purified protein derivative (PPD)  (Parke, Davis & Co., Detroit, Mich.). 
To test for suppression of MIF activity, 25-100 x  103 spleen cells of normal or 20-wk infected 
mice were added to 1 ×  106 SPEC, then the MIF assay was performed in the presence of 1 ttg/ 
ml of SEA. If the expected migration inhibition was abrogated, it was concluded that cells that 
suppress MIF activity were present  in the spleen cell population. 
Statistical Methods of Calculations.  The  Student's  t  test  was  used  to  determine  significant 
differences between migration  areas of control  and  experimental  groups.  Values of P  >  0.05 
were considered not significant. Percent migration inhibition was calculated as follows: 
migration area of control -- migration area of experimental~  × 
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Inhibitions of~20% represented significant differences in migration areas. Data from suppressor 
cell assays also include value for the degree of suppression, calculated as follows: 
percent inhibition of control --  percent inhibition of experimenta~ X 100. 
percent inhibition of control 
Results 
Demonstration of Suppressed MIF Activity During Spontaneous Modulation.  In a previous 
study, Boros et al.  (7)  showed that  the onset of modulated granuloma formation is 
paralleled by a decreased production of MIF by SEA-stimulated spleen cells. Because 
those results were obtained from outbred mice, with xenogeneic peritoneal macro- 
phages  used  to  detect  MIF  activity,  the  experiments  were  repeated  in  a  totally 
syngeneic system. Spleen cells of 8- (8-wk SP) and 20-wk (20-wk SP) infected CBA/J 
mice were cultured for 24 h with graded doses of SEA. Supernates were then collected 
and  tested for MIF activity with NPEC as indicator cells. As shown in Fig.  1, the 
previous  findings  were confirmed with  inbred  CBA  mice.  Supernates  of 8-wk  SP 
cultures  showed  strong  MIF  activity  over  the  antigen  dose  range  employed.  In 
contrast,  the  antigen-stimulated  20-wk  SP  cultures  produced  no  significant  MIF 
activity. 
Essentially identical results were obtained by directly supplementing NPEC with 
8- or 20-wk SP. Graded doses of spleen cells were added to the NPEC, and a direct 
MIF assay was carried out in the presence of 1 #g/ml of SEA. Fig. 2 shows that 8-wk 
SP caused significant migration inhibition, whereas 20-wk SP or normal spleen cells 
(NSP)  did  not.  Because  direct  supplementation  of NPEC  accurately reflected the 
activities observed in supernates, this technique provided a rapid method of assaying 
for MIF and obviated the need for the collection and storage of supernates. 
Demonstration of Active Suppression of MIF Production by 20-wk SP.  The lack of MIF 
activity in supernates of 20-wk SP suggested that  regulatory mechanism(s)  may be 
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FIG.  1.  Comparison of MIF activity produced by (0)  8-wk SP and (O)  20-wk SP in response to 
graded doses  of SEA. Points represent the mean of two experiments. 1402  REGULATION  OF  MIGRATION  INHIBITION  FACTOR  PRODUCTION 
F- 
50 
20i 
-I0  ! 
8 wk  20 wk  Normal 
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of spleen cells were added to  106 NPEC (solid, 2.5 ×  104; open, 5 ×  104; and hatched,  i  ×  105) and 
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FIC.  3.  Suppression of MIF activity of 8-wk SP by 20-wk SP. Equal numbers of spleen cells from 
8- and 20-wk infected mice were mixed and added to  106 NPEC  in graded doses (open, 5  x  104; 
hatched, 1 ×  l0  s) and then assayed for MIF activity. Bars represent mean and SE of three separate 
experiments. 
operating to prevent lymphokine production. Therefore, it was of interest to examine 
the effect  of 20-wk SP on the production of MIF by 8-wk SP.  Fig.  3 shows that  the 
MIF activity of 8-wk SP was totally ablated in the presence of 20-wk SP. In contrast, 
NSP had no effect on MIF activity. To determine if 20-wk SP produced a factor that 
directly inactivated  MIF, supernates of 20-wk SP were mixed with equal volumes of 
MIF-rich supernates and were tested for MIF activity. Apparently, 20-wk SP did not STEPHEN  W.  CHENSUE,  DOV  L.  BOROS,  AND  CHELLA  S.  DAVID  1403 
produce factors that negated  the effect  of MIF,  as  full  activity was  retained  in the 
supernatant mixtures (Fig. 4). 
The suppressive effect of 20-wk SP was also demonstrable with SPEC rather than 
8-wk SP. The SPEC consistently showed migration inhibition in the presence of SEA 
or PPD  and provided  a  reliable,  independent  system  to examine  the regulation of 
MIF  production. As shown in Fig.  5, the addition of 20-wk SP to SPEC  abrogated 
MIF activity in a dose-dependent fashion, whereas NSP had no such effect. 
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Fro.  4.  Failure of supernates of cultured 20-wk SP to inactivate MIF-rich supernates of 8-wk SP. 
Pooled supernates of cultured spleen cells from four to five normal or 20-wk infected mice were 
added to an equal volume of supernate prepared  from 8-wk SP. These mixtures were diluted  1:1 
with fresh medium and then assayed for MIF activity.  Five individual supernates from 8-wk SP 
were treated in this manner. Bars show the mean and SE of the five supernates. The MIF activities 
of the pooled supernates from 20-wk SP and NSP are also shown. 
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FIG.  5.  Suppression of the MIF activity of peritoneal exudate cells from SEA sensitized mice by 
20-wk SP. 20-wk SP (O)  or NSP (O) were added to  10  ~ SPEC in graded doses and then assayed for 
MIF activity. Points represent the mean ±  SE of three separate experiments. 1404  REGULATION OF MIGRATION INHIBITION FACTOR PRODUCTION 
Specificity of the Suppression of MIF Production.  If suppression  is  mediated  by SEA- 
specific cells,  then  migration  inhibition  elicited  by PPD  presumably  should  not  be 
abrogated by 20-wk SP. This was tested by supplementing SPEC with doses of 20-wk 
SP and assaying in parallel  for SEA- or PPD-elicited MIF production. Table I shows 
that  the  response  to  SEA  was  indeed  suppressed,  whereas  that  of the  adjuvant- 
sensitized lymphocytes was unimpaired. 
Characterization of Cells Involved in  MIF Production with  Thy-I  and Lyt Antisera.  To 
characterize the cell(s)  that produced MIF, NPEC were supplemented  with 8-wk SP 
that  had  been  pretreated  with  anti-Thy-l.2  and  anti-Lyt  alloantisera  and  comple- 
ment.  As  shown  in  Fig.  6  both  anti-Thy-1  and  anti-Lyt-l.1  sera  abrogated  MIF 
activity.  In  contrast,  anti-Lyt-2.1  treatment  tended  to  augment  or  enrich  MIF- 
producing cells. This was manifested by the appearance of significant MIF activity at 
the lower dose of spleen cells (5 ×  104) that was suboptimal  for MIF detection in the 
normal mouse serum (NMS)-treated control. These results indicate that Lyt- 1  + T  cells 
are  responsible  for MIF production  in  the  schistosome-infected  mice.  Furthermore, 
mixing the anti-Lyt-1.1  and anti-Lyt-2.1  antisera-treated  spleen populations resulted 
in a loss of significant MIF activity, which suggests a possible suppressive role for Lyt- 
2 + cells. 
Characterization of Cells Involved in MIF Production with Anti-I-Subregion Sera.  Further 
chara.cterization  of MIF-producing T  cells  was performed  with  a  battery  of anti-I- 
subregion sera.  T  cells, enriched  from 8-wk SP were treated  with the various anti-I- 
subregion  sera  and  complement  before  the  addition  to NPEC  and  MIF  assay  was 
carried  out.  As  shown  in  Fig.  7,  sera  directed  against  A k-, jk_,  Ek_, Eck_,  and  C k- 
subregion determinants  had no significant effect, which suggests that  I-region deter- 
minants are not expressed by MIF-producing T  cells. 
Characterization of Cells That Suppress MIF Production with Thy-1 and Lyt Antisera.  To 
identify  the  cells  involved  in  the  suppression  of MIF  production,  20-wk  SP  were 
treated with anti-Thy- 1.2,  anti-Lyt- 1.1, or anti-Lyt-2.1  alloantisera  and complement 
before addition to SPEC. Table II shows that anti-Thy-l.2 serum totally ablated the 
suppressive effect of 20-wk SP  (compare groups  1 and  2).  Furthermore,  suppression 
was  eliminated  by  treatment  with  anti-Lyt-2.1  but  not  with  anti-Lyt-l.1  serum 
TABLE  I 
Antigen Specificity of the Suppression of MIF Production 
Antigen 
Number of 
spleen cells  Migration inhibitions  Degree  of sup- 
added*  pression 
(X 10 -4) 
SEA 
PPD 
%  % 
0  35.9 + 4.7  -- 
5.0  18.4 + 2.5  48.7 
10.0  14.6 + 3.9  59.3 
0  22.6 + 6.5  -- 
5.0  29.5 ::tz  3.6  0 
10.0  22.0 + 3.2  2.7 
* The indicated doses of 20-wk SP were added to  l0 6 SPEC and then assayed 
for MIF activity in the presence of 1 #g/ml SEA or 5 #g/ml PPD. 
:~ The values represent the mean + SE of three separate experiments. 1405 
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FIG. 6.  Characterization  of MIF-producing cells  with  anti-Thy-I  and  anti-Lyt  antisera.  Bars 
represent the mean and SE of three to four separate experiments. 8-wk SP were treated with serum 
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assayed for MIF activity. 
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Fro.  7.  Characterization of MIF-producing cells with anti-I-subregion antisera. Bars represent the 
mean and SE of three to four separate experiments. T cell-enriched fractions of 8-wk SP were treated 
with serum and complement, added to 10  e NPEC in graded doses (open, 5 ×  104; hatched, 1 X 10s), 
and then assayed for MIF activity. 
(compare  groups  3-5).  These  data  indicated  a  clear involvement  of Ly-2 +  T  cells in 
the suppression of MIF  production. 
Characterization  of  Cells  That  Suppress  MIF  Production  with  Anti-I-Subregion 
Antisera.  Further characterization  of cells suppressing MIF  production  was performed 
on T  cell-enriched  fractions  from  20-wk  SP.  As  shown  in  Fig.  8,  the  splenic T  cell 1406  REGULATION  OF  MIGRATION  INHIBITION  FACTOR  PRODUCTION 
TAHLE  II 
Characterization of the Cells That Suppress the Production of MIF with Anti-Thy-1  and 
Anti-Lyt  Antisera 
Number of 
spleen cells  Migration inhi-  Degree of 
Group  Serum treatment  added*  bitionJ~  suppression 
(X  10 -4) 
%  % 
1  NMS  0  21.5 +  2.7  -- 
(AKR)  5.0  6.7 +  3.6  69.0 
10.0  -7.9 +  6.6  136.7 
2  anti-Thy-l.2  0  21.5 ±  2.7  -- 
5.0  36.8 ±  12.4  0 
I0.0  43.4 ±  2.3  0 
3  NMS  0  32.4 ±  5.0  -- 
(BALB/c ×  C57BL/6)  2.5  9.6 +  4.3  70.4 
5.0  14.4 ±  8.2  55.6 
4  anti-Lyt-l.1  0  32.4 ±  5.0  -- 
2.5  12.4 +  6.5  61.7 
5,0  15.1 +  3.9  53.4 
5  anti-Lyt-2.1  0  32.4 ±  5.0  -- 
2.5  30.8 +  4.1  5.0 
5.0  45.7 ±  3.9  0 
* 20-wk SP were treated with serum and complement and added to SPEC at the indicated 
doses and then assayed for MIF activity. 
z~ The values represent the mean +  SE of three to four separate experiments. 
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FIc.  8.  Suppression of MIF activity by T  cell-enriched fractions from 20-wk SP. T  cell fractions of 
(O)  NSP and  (O)  20-wk SP were added to  106 SPEC  in graded doses and then assayed for MIF 
activity. Points represent the mean +  SE of two experiments. 
fraction  of 20-wk-infected,  but  not  normal,  mice  was  capable  of suppresing  the  MIF 
activity  of  SPEC.  These  T  cells  were  subsequently  treated  with  various  anti-I- 
subregion  sera  and  complement  and  then  were  assayed  for their  capacity  to suppress 
the  MIF  activity  of SPEC.  As  shown  in  Table  III,  suppression  was  abrogated  with STEPHEN  W.  CHENSUE,  DOV  L.  BOROS,  AND  CHELLA  S.  DAVID 
TABLE  III 
Characterization of the Cells That Suppress the Production of MIF with Anti-I-Subregion 
Antisera 
1407 
Number of 
Spleen T  Migration inhi-  Degree of 
Group  Serum treatment  cells 
added*  bition:[:  suppression 
(×  10  -~) 
%  % 
1  NMS  0  26.6 ±  2.6  -- 
(BALB/c ×  C57BL/6)  2.5  7.0  ±  6.0  73.7 
5.0  2.9 ±  5.0  89.1 
2  anti-ABJ  k  0  26.6 ±  2.6  -- 
(A.BY ×  B10.HTT)  2.5  30.4 ±  10.2  0 
anti-A.TL  5.0  31.5 ±  4.2  0 
3  anti-A  k  0  26.6 ±  2.6  -- 
[ATFR.5 ×  BI0.S(9R)]  2.5  10.8 ±  5.7  59.4 
anti-A.TL  5.0  0.6 +  10.6  97.7 
4  anti-J  k  0  26.6 +  2.6  -- 
B 10.HTT anti-B 10.S(9R)  2.5  32.0 ±  3. l  0 
5.0  26.0 ±  9.8  0 
5  anti-E  k  0  26.6 ±  2.6  -- 
(BI0.D2 x  A.BY)  2.5  -4.8 ±  20.0  118.0 
anti-B10.A(3R)  5.0  -9.7 ±  12.3  136.5 
6  anti-C  k  0  26.6 ±  2.6  -- 
(A ×  BI0) anti-Bl0.AM  2.5  21.4 ±  3.2  19.5 
5.0  27.4 ±  6.0  0 
* T  cell-enriched fractions of 20-wk SP were treated with serum and complement and added 
to SPEC at the indicated doses and then assayed for MIF activity. 
The values represent the mean +  SE of three separate experiments. 
anti-ABJ  a, anti-J  k, and anti-C k sera, but was unaffected by anti-A  k, anti-E  k, or NMS. 
Taken  together, these  results  indicate  that  I-J  and  I-C  gene-encoded products are 
expressed on cells involved in the suppression of MIF production. 
Discussion 
Evidence accumulated  in  recent  years  indicates  that  lymphokines  may play  an 
important role in the initiation and maintenance of the granulomatous host response 
to schistosome eggs.  In  sensitized  guinea  pigs,  augmented  granulomatous  reaction 
coincided with the appearance of MIF activity in the peritoneal lymphocytes (22). 
Conversely, the  diminished  (spontaneously modulated)  granulomatous  response of 
chronically infected mice was correlated with the cessation of lymphokine production 
(7,  8).  Recently,  adoptive  transfer  studies  have  shown  that  modulation  of  the 
granulomatous  response  may  be  mediated  by  T  suppressor  lymphocytes  (13-15). 
Because cyclophosphamide treatment of chronically infected mice reversed the mod- 
ulation  of the  granulomatous  response,  it  is  possible  that  lyrnphokine-producing 
lymphocytes are still present in the infected mice but are under the regulation of a 
suppressor cell(s) (14). Thus, modulation of the host granulomatous response may be 
based on T-T cell interaction, with the resultant curtailment of mediator production 
and cellular mobilization. 
In the present in vitro investigations we show that such a mechanism may possibly 1408  REGULATION OF  MIGRATION INHIBITION FACTOR PRODUCTION 
function in murine schistosomiasis during the stage of the modulated response. Splenic 
lymphocytes of mice with modulated granulomatous responses, mixed with mediator- 
producing splenic cells of animals that displayed peak granulomatous response indeed 
abrogated mediator production by the latter. A similar effect was seen when instead 
of splenocytes, antigen-sensitized peritoneal lymphocytes were used as target cells for 
the  suppression.  The  suppression  was elicited  by specific  antigen  and,  apparently, 
acted  at  the  cellular  level  rather  than  on  the  released  mediator.  The  lymphocytes 
involved in mediator production and suppression were then characterized. The MIF- 
producer lymphocytes present in the spleens of 8-wk infected mice were shown to be 
T  cells that belong to a  Lyt-1  + subpopulation that lacked I region-encoded determi- 
nants.  This  profile  is  consistent  with  recent  reports  that  characterized  mediator- 
secreting lymphocytes (23-25).  In contrast to these findings, Newman et al. (26)  have 
shown that Lyt-2  + cells also produce MIF. However, their results were obtained with 
mixed  lymphocyte cultures  (MLC)  and  not  soluble  protein  antigens.  The  lack  of 
detectable Ia antigens on the surface of the Lyt- 1  ÷ MIF-producing lymphocytes makes 
these cells similar to, or identical with, the TDn cells active in the adoptive transfer of 
delayed-type hypersensitivity (27). 
Lymphocytes from the spleens of 20-wk infected mice that abrogated the in vitro 
production of MIF-active mediator were identified as T  cells that belong to the Lyt- 
2 +  subpopulation  classified  as  suppressor/killer  cells  by  Cantor  and  Boyse  (28). 
Although  clearly demonstrable at  20 wk of infection,  suppressor cells seemed to be 
present, albeit in smaller numbers, in 8-wk SP. When an enriched Lyt-2  + population 
from such  spleens  was  added  to  Lyt-1  + cells,  abrogation  of MIF activity was seen 
(Fig.  6).  Further  characterization  of  the  suppressor  cells  revealed  that  they  also 
expressed the  I-J- and  I-C-subregion gene products.  As yet  it  is  not  known  if such 
markers  are  expressed  on  the  same  or  separate  different  cells.  These  findings  are 
consistent  with  reports from other laboratories that  have shown  the presence of I-J 
antigen on the membranes of suppressor T  cells (29), auxiliary suppressor T  cells (30), 
and soluble suppressor factors active in  the regulation  of antibody production  (31) 
and  the  suppression  of contact  sensitivity  (32).  So  far,  the  I-C  subregion-encoded 
determinants  have  been  associated  with  soluble  suppressive  factors  active  in  cell 
proliferation of MLC (33).  We furnish evidence that I-J  + and I-C  + T  suppressor (Ts) 
lymphocytes  are  involved  in  yet  another  cell-mediated  system:  the  regulation  of 
lymphokine production.  It is still to be seen whether such cells would exert a similar 
effect locally, within  the  granulomas.  Our  previous  finding  that  shows  the  virtual 
absence  of Ia  +  T  lymphocytes in  the  granulomas  of 8-wk  infected  mice,  but  the 
pronounced presence of such cells in the modulated lesions of 20-wk infected animals, 
seems to support this notion (15).  A phenotypic and functional analysis of the various 
subpopulations of the granuloma lymphocytes is presently under way in our labora- 
tory to answer this question.  Such  an analysis should shed light on local interaction 
of Lyt-2  +,  Ia  +  T  cells  with  precursor  suppressor  cells  (34)  and/or  the  Lyt-1  +,  Ia- 
mediator producer lymphocytes. 
As  yet  there  are  only  a  few  reports  on  Ts  lymphocyte-mediated  regulation  of 
lymphokine production. Fox and Rajaraman (35)  have shown that T  lymphocytes of 
sensitized  guinea  pigs  and  humans  suppress  in  vitro  MIF  production.  In  another 
report by Suko et al. (36), exposure of sensitized lymphocytes to large doses of antigen 
elicited  the  production  of a  soluble  factor,  which  nonspecifically  suppressed  MIF STEPHEN W.  CHENSUE, DOV  L.  BOROS,  AND CHELLA S.  DAVID  1409 
production  in  heterologously sensitized  lymphocytes.  Such  factor(s)  may  be  the 
products of the "Is cells we have described. Furthermore, in view of previous descrip- 
tions of soluble suppressor factors (31-33) these might be predicted to express I-region 
gene products. We are currently investigating these possibilities. 
Ts  cell  regulation  of cell-mediated  inflammation  may  be  relevant  to  human 
schistosomiasis as well as other granulomatous diseases. Ottesen et al. (37) have shown 
that anti-SEA blastogenic responses of peripheral blood lymphocytes from patients 
with  schistosomiasis mansoni  decreases  with  the  duration  of infection.  Moreover, 
Colley et al. (38) have identified factor(s) in the sera of chronically infected patients 
that suppress blastogenic responses to parasite antigens. These changes were attributed 
to Ts cell activity; however, their relationship to granuloma formation has yet to be 
established. Suppressor cells that cause depressed delayed-dermal responses have been 
described in experimental leprosy (39) and histoplasmosis (40). Interestingly, compar- 
ison of groups of patients with tuberculoid or lepromatous leprosy revealed that the 
peripheral blood lymphocytes of the latter have a  reduced capacity to produce MIF 
(41)  or  maerophage  aggregation  factor  (42)  in  response  to  lepromin.  One  may 
postulate from such studies that Ts cells are blocking lymphokine-mediated granuloma 
formation,  thereby  causing  the  dissemination  of organisms  seen  in  lepromatous 
leprosy. A  better  understanding of the  mechanism(s)  active  in  the  modulation of 
granulomatous  inflammation should  help  to  assess  the  risks  and  benefits  of this 
phenomenon and will improve the clinical management of various granulomatous 
diseases. 
Summary 
Host granulomatous inflammation in murine schistosomiasis mansoni is a  T  cell- 
mediated immune response, which, at the chronic stage of the disease, undergoes T 
suppressor lymphocyte-dependent modulation. In the present study this phenomenon 
was further analyzed in vitro.Spleen cells of mice undergoing modulation (20 wk of 
infection) when mixed with spleen cells of animals exhibiting vigorous granulomatous 
responses  (8 wk of infection) abrogated in vitro migration inhibition factor (MIF) 
production  by  the  latter.  Characterization  of the  delayed-type hypersensitivity T 
lymphocytes involved in lymphokine production showed that they belonged to the 
Lyt-1  + subset and did not express I region-encoded antigens. In contrast, T  lympho- 
cytes involved in the suppression of MIF activity belonged to the Lyt-2  ÷ subpopulation 
of cells, which expressed I-J- and I-C-subregion determinants. These results suggest 
that the modulation of the granulomatous hypersensitivity response in mice is the 
result of T-T cell interaction with subsequent regulation of inflammatory lymphokine 
production. 
Received  for publication 9 January 1980. 
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